Academix

About
What does Academix do?
Academix is a partnering platform that leverages machine learning algorithms to efficiently identify and match leading academic researchers globally with industry R&D challenges, bridging the gap between industry and academia.
What is Academix's revenue?
StartupHub estimates Academix's annual revenue at $333K (range $204K to $682K, 65% confidence), based on comparable companies in the sector.
When was Academix founded?
Academix was founded in 2017.
What industry does Academix operate in?
Academix operates in Healthcare, Knowledge, Biotech, HealthTech, Drug Discovery, R&D.
How many employees does Academix have?
Academix has approximately 2 people on record.
What is Academix's current status?
Academix's current operating status is: Inactive.
Ship of Theseus is developing a fleet of biologics based on the homeobox (HOX) family of transcription factors to create novel pharmaceuticals.
An independent research reference providing accessible, accurate, and transparent information on bioactive peptides and peptide science.
Provider-supervised peptide therapy, NAD+ support, and cognitive enhancement for cellular renewal, recovery, and healthy aging.
Leading AI agency in Guwahati specializing in biological intelligence, generative AI, and regulatory systems for Asia's underrepresented populations.
Spearmint Resources Inc. is a Canadian mineral exploration company focused on lithium, gold, and antimony projects.
Eccoscience is a startup focused on developing AI-powered solutions for scientific research and discovery.
Feef is a voice-native AI agent that designs personalized fitness, nutrition, supplement, and recovery protocols, integrating them directly into your calendar.
Longevity and metabolic health platform offering personalized insights and interventions.
An entrant is a company tagged Biotech whose domain was first registered in the window, counted from registry records in the StartupHub directory. 3 of them registered in the last 30 days. Registry detection runs two to three weeks behind registration, so recent weeks are a floor.
No comments yet. Be the first to share your take.

